Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
NanoCellect Biomedical Expands Distribution to Australia and New Zealand 2019-07-24 21:57
Verb Surgical Announces Kurt Azarbarzin as President and CEO 2019-07-24 21:00
Richard C. Finch joins Clarivate Analytics to drive expansion of Life Sciences Consulting Services 2019-07-24 21:00
Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders 2019-07-24 20:55
111 Signs Strategic Cooperation with Harbin Pharmaceutical Group 2019-07-24 20:00
Siemens Healthineers Earns Acclaim from Frost & Sullivan for Employing AI to Reduce Variability in Imaging 2019-07-24 19:00
Global Cord Blood Corporation Files Its Annual Report on Form 20-F 2019-07-24 04:16
Announcing 3B SMART ANATOMY - The New Generation of Anatomical Models 2019-07-24 02:29
111 Wins Recognition as Pioneer of New Healthtech 2019-07-23 21:53
Ping An introduces doctor's AI assistant to Singapore 2019-07-23 21:19
Flex Earns Acclaim from Frost & Sullivan for Harnessing Its Cross-industry Influence and R&D Prowess to Aid Reliable Medical Device Production 2019-07-23 21:19
Shanghai Concord Medical Cancer Center has Accepted Medical Insurance Settlement from Patients from certain Yangtze River Delta Regions 2019-07-23 18:03
Innopresso launches Indiegogo campaign for its touchpad-keyboard Mokibo 2019-07-23 15:30
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent 2019-07-23 15:00
Huge CPhI & P-MEC China a direct result of surging manufacturing 2019-07-23 13:18
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections 2019-07-23 12:48
Shinsung TK Paves Way for IoT Healthcare in Asia 2019-07-23 12:00
Dermatix(R) Unveils New Product Breakthrough for Acne Scarring Solution 2019-07-23 10:00
Ping An Good Doctor and Minsheng Insurance Reached Strategic Cooperation to Create New Values Under "Insurance + Health" Model 2019-07-22 15:22
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML 2019-07-22 12:17
1 894 895 896 897 898 1624